Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19

Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is uncle...

Full description

Bibliographic Details
Main Authors: Benhur Sirvan Cetin, Ayşenur Paç Kısaarslan, Ali Baykan, Başak Nur Akyıldız, Hakan Poyrazoglu
Format: Article
Language:English
Published: Galenos Publishing House 2022-06-01
Series:The Journal of Pediatric Academy
Subjects:
Online Access:https://jpediatricacademy.com/index.php/jpa/article/view/182
_version_ 1797767373252460544
author Benhur Sirvan Cetin
Ayşenur Paç Kısaarslan
Ali Baykan
Başak Nur Akyıldız
Hakan Poyrazoglu
author_facet Benhur Sirvan Cetin
Ayşenur Paç Kısaarslan
Ali Baykan
Başak Nur Akyıldız
Hakan Poyrazoglu
author_sort Benhur Sirvan Cetin
collection DOAJ
description Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C.
first_indexed 2024-03-12T20:37:48Z
format Article
id doaj.art-0c150e7618924537b2779fc0f7e4c048
institution Directory Open Access Journal
issn 2718-0875
language English
last_indexed 2024-03-12T20:37:48Z
publishDate 2022-06-01
publisher Galenos Publishing House
record_format Article
series The Journal of Pediatric Academy
spelling doaj.art-0c150e7618924537b2779fc0f7e4c0482023-08-01T11:23:16ZengGalenos Publishing HouseThe Journal of Pediatric Academy2718-08752022-06-0133879410.51271/jpea-2022-182132Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19Benhur Sirvan Cetin0https://orcid.org/0000-0002-8470-4907Ayşenur Paç KısaarslanAli BaykanBaşak Nur AkyıldızHakan PoyrazogluErciyes UniversityMultisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C.https://jpediatricacademy.com/index.php/jpa/article/view/182covid-19mis-cguidelinepediatric
spellingShingle Benhur Sirvan Cetin
Ayşenur Paç Kısaarslan
Ali Baykan
Başak Nur Akyıldız
Hakan Poyrazoglu
Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
The Journal of Pediatric Academy
covid-19
mis-c
guideline
pediatric
title Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
title_full Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
title_fullStr Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
title_full_unstemmed Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
title_short Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
title_sort erciyes clinical guideline for multisystem inflammatory syndrome in children mis c associated with covid 19
topic covid-19
mis-c
guideline
pediatric
url https://jpediatricacademy.com/index.php/jpa/article/view/182
work_keys_str_mv AT benhursirvancetin erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19
AT aysenurpackısaarslan erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19
AT alibaykan erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19
AT basaknurakyıldız erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19
AT hakanpoyrazoglu erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19